Medicare Enrolled
Dr. Thomas Joseph, MD
Hematology · Santa Clarita, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Joseph from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Joseph?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Joseph
Dr. Thomas Joseph is a hematology specialist in Santa Clarita, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Joseph performed 19,067 Medicare services across 991 unique beneficiaries.
Between the years covered by Open Payments, Dr. Joseph received a total of $9,329 from 48 pharmaceutical and/or device companies across 161 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Joseph is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 6% volume in CA
$9,329 industry payments
Medicare Practice Summary
Medicare Utilization ↗19,067
Medicare services
Top 6% in CA for hematology
991
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,004 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 11,800 | $43 | $194 |
| Denosumab injection (Prolia/Xgeva) | 5,040 | $18 | $81 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
641 | $98 | $481 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
348 | $64 | $286 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
228 | $121 | $606 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
136 | $12 | $81 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
127 | $14 | $93 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
106 | $50 | $341 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
82 | $26 | $134 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
77 | $59 | $269 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
68 | $25 | $109 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
52 | $59 | $295 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
51 | $70 | $341 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
49 | $109 | $467 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
43 | $1 | $4 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
39 | $154 | $672 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
39 | $143 | $633 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
35 | $142 | $623 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
27 | $26 | $220 |
| New patient office visit, complex (60-74 min) | 26 | $187 | $821 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
25 | $22 | $103 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
15 | $10 | $155 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
13 | $68 | $306 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.0% high complexity
90.4% medium
7.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,329
Total received (2018-2024)
Avg $1,333/year across 7 years
Top 42% in CA for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
161
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,655 (60.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,190 (34.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$483 (5.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$759
2023
$608
2022
$728
2021
$710
2020
$281
2019
$4,995
2018
$1,248
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$165
Kite Pharma, Inc.
$150
Blueprint Medicines Corporation
$129
Tempus AI, Inc
$116
INTUITIVE SURGICAL, INC.
$96
AstraZeneca Pharmaceuticals LP
$83
ERBE USA INC
$20
Top 3 companies account for 58.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,242
GENZYME CORPORATION
$504
E.R. Squibb & Sons, L.L.C.
$473
Amgen Inc.
$445
GlaxoSmithKline, LLC.
$383
Seattle Genetics, Inc.
$273
Abbott Laboratories
$265
COMSORT, Inc
$250
Merck Sharp & Dohme Corporation
$223
BeiGene USA, Inc.
$220
PFIZER INC.
$202
Medtronic USA, Inc.
$183
Eisai Inc.
$166
Genentech USA, Inc.
$161
Gilead Sciences, Inc.
$153
Kite Pharma, Inc.
$150
Pharmacyclics LLC, An AbbVie Company
$147
SANOFI-AVENTIS U.S. LLC
$139
Blueprint Medicines Corporation
$129
Merck Sharp & Dohme LLC
$125
BIOTRONIK INC.
$117
Tempus AI, Inc
$116
Ethicon US, LLC
$115
Lilly USA, LLC
$111
Myriad Genetic Laboratories, Inc.
$107
AbbVie, Inc.
$106
INTUITIVE SURGICAL, INC.
$96
Pinnacle Biologics, Inc
$77
Puma Biotechnology, Inc.
$77
Novartis Pharmaceuticals Corporation
$74
Janssen Biotech, Inc.
$67
Takeda Pharmaceuticals U.S.A., Inc.
$63
EISAI INC.
$44
Clovis Oncology, Inc.
$40
Foundation Medicine, Inc.
$32
Astellas Pharma US Inc
$25
TESARO, Inc.
$25
Janssen Pharmaceuticals, Inc
$25
INSYS Therapeutics Inc
$24
TOLMAR Pharmaceuticals, Inc.
$22
Incyte Corporation
$20
ERBE USA INC
$20
Alexion Pharmaceuticals, Inc.
$20
BTG International, Inc.
$17
Karyopharm Therapeutics Inc.
$17
Seagen Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$12
Top 3 companies account for 45.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Avastin · BAVENCIO · BRUKINSA · CABLIVI · CALQUENCE · COROFLOW · CRYO2 · CYRAMZA · DARZALEX · Da Vinci Surgical System · ELIGARD · ELIQUIS · ELITEK · EVENITY · Erleada · FOUNDATIONONE · GAZYVA · GILOTRIF · Halaven · IBRANCE · IMFINZI · INLYTA · Imbruvica · JAKAFI · KEYTRUDA · KISQALI · KYPHON Balloon Kyphoplasty · Kyprolis · LENVIMA · LIBTAYO · LORBRENA · LYNPARZA · Lenvima · MVASI · NINLARO · Nerlynx · Neuwave · Nplate · OCREVUS · OPDIVO · OPTIS · PIQRAY · PROMACTA · Perjeta · Photofrin · Rubraca · SARCLISA · SOLIQUA 100/33 · SUTENT · SYNDROS · TALZENNA · TRELEGY ELLIPTA · Trodelvy · ULTOMIRIS · VERZENIO · VORAXAZE · Venclexta · XARELTO · XGEVA · XPOVIO · XTANDI · Xofigo · Yescarta · ZEJULA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (61%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematologists within 10 mi
2
Per 100K population
0.0
County median income
$87,760
Nearest hospital
HENRY MAYO NEWHALL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Joseph is a mixed practice specialist, with above-average Medicare volume (top 6% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Joseph experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Joseph performed 11,800 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Joseph receive payments from pharmaceutical companies?
Yes. Dr. Joseph received a total of $9,329 from 48 companies across 161 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Joseph's costs compare to other hematologists in Santa Clarita?
Dr. Joseph's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Joseph) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Santa Clarita
Browse hematologists in Santa Clarita ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in CA
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in CA
Which CA hematologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology